| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CDT Equity Inc. | CFO, Director | Common Stock | 480,024 | $648,032 | $1.35 | 19 Sep 2025 | Direct |
| CONDUIT PHARMACEUTICALS INC. | CFO, Director | Stock Option (Right to Buy) | 1,890,000 | $173,691 | $0.0919 | 18 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CDT | CDT Equity Inc. | 19 Sep 2025 | 1 | $0 | 4 | CFO, Director | 19 Sep 2025, 16:46 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 18 Nov 2024 | 1 | +$173,691 | 4 | Interim CFO, Director | 20 Nov 2024, 16:30 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 11 Jun 2024 | 1 | $0 | 4 | Interim CFO, Director | 11 Jun 2024, 17:53 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 01 Dec 2023 | 1 | +$1,232,223 | 4 | Director | 05 Dec 2023, 17:20 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 22 Sep 2023 | 0 | $0 | 3 | Director | 26 Sep 2023, 18:42 |